Deutsche Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-113
| Closed | -$10.5K | – | 3639 |
|
|
2024
Q2 | $10.5K | Buy |
+113
| New | +$10.1K | ﹤0.01% | 3460 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$7.62K | – | 3949 |
|
|
2023
Q1 | $7.62K | Hold |
100
| – | – | ﹤0.01% | 3804 |
|
|
2022
Q4 | $8.3K | Hold |
100
| – | – | ﹤0.01% | 3865 |
|
|
2022
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 3859 |
|
|
2022
Q2 | $7K | Sell |
100
-18,963
| -99% | -$1.42M | ﹤0.01% | 4033 |
|
|
2022
Q1 | $1.71M | Hold |
19,063
| – | – | ﹤0.01% | 1992 |
|
|
2021
Q4 | $2.13M | Hold |
19,063
| – | – | ﹤0.01% | 1951 |
|
|
2021
Q3 | $2.4M | Hold |
19,063
| – | – | ﹤0.01% | 1972 |
|
|
2021
Q2 | $2.58M | Hold |
19,063
| – | – | ﹤0.01% | 1997 |
|
|
2021
Q1 | $2.59M | Hold |
19,063
| – | – | ﹤0.01% | 1979 |
|
|
2020
Q4 | $2.68M | Buy |
19,063
+1,700
| +10% | +$218K | ﹤0.01% | 1728 |
|
|
2020
Q3 | $1.94M | Hold |
17,363
| – | – | ﹤0.01% | 1762 |
|
|
2020
Q2 | $1.94M | Buy |
17,363
+17,359
| +433,975% | +$1.71M | ﹤0.01% | 1803 |
|
|
2020
Q1 | $0 | Sell |
4
-3,040
| -100% | -$269K | ﹤0.01% | 4879 |
|
|
2019
Q4 | $289K | Sell |
3,044
-5,640
| -65% | -$488K | ﹤0.01% | 3020 |
|
|
2019
Q3 | $662K | Sell |
8,684
-887,803
| -99% | -$73.8M | ﹤0.01% | 2545 |
|
|
2019
Q2 | $78.6M | Sell |
896,487
-1,053,740
| -54% | -$89.9M | 0.05% | 415 |
|
|
2019
Q1 | $177M | Buy |
1,950,227
+474
| +0% | +$40.3K | 0.11% | 206 |
|
|
2018
Q4 | $140M | Sell |
1,949,753
-52,406
| -3% | -$4.22M | 0.1% | 209 |
|
|
2018
Q3 | $192M | Sell |
2,002,159
-1,150,709
| -36% | -$112M | 0.1% | 228 |
|
|
2018
Q2 | $300M | Sell |
3,152,868
-2,013,968
| -39% | -$185M | 0.15% | 134 |
|
|
2018
Q1 | $453M | Buy |
+5,166,836
| New | +$472M | 0.22% | 87 |
|
|
2015
Q1 | – | Sell |
-2,867,433
| Closed | -$178M | – | 6027 |
|
|
2014
Q4 | $178M | Buy |
2,867,433
+2,805,069
| +4,498% | +$160M | 0.11% | 220 |
|
|
2014
Q3 | $3.24M | Buy |
62,364
+54,546
| +698% | +$2.78M | ﹤0.01% | 2149 |
|
|
2014
Q2 | $400K | Sell |
7,818
-508,896
| -98% | -$22.9M | ﹤0.01% | 3635 |
|
|
2014
Q1 | $24.5M | Buy |
516,714
+53,094
| +11% | +$2.72M | 0.02% | 820 |
|
|
2013
Q4 | $20.1M | Buy |
463,620
+434,142
| +1,473% | +$18M | 0.01% | 915 |
|
|
2013
Q3 | $1.27M | Sell |
29,478
-4,785,417
| -99% | -$194M | ﹤0.01% | 2783 |
|
|
2013
Q2 | $167M | Buy |
+4,814,895
| New | +$169M | 0.14% | 176 |
|
Other funds holding XBI
Deutsche Bank's XBI Position: Q3 2024 in Review
Deutsche Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 113 shares — an estimated $10.5K sold.
Deutsche Bank first reported a position in XBI in Q2 2013 and held it in 29 quarters. The position peaked at $453M in Q1 2018. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.
- Deutsche Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
- Deutsche Bank sold 113 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $10.5K.
- Deutsche Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 29 quarters.
- Deutsche Bank's State Street SPDR S&P Biotech ETF position peaked at $453M in Q1 2018.
- 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.
Based on Deutsche Bank's 13F filing for Q3 2024, filed 13 Nov 2024.